Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects
Not Applicable
Completed
- Conditions
- Change in Total Body Fat Mass Percentage Loss Versus Body Weight
- Interventions
- Dietary Supplement: Sinetrol® XpurDietary Supplement: Placebo
- Registration Number
- NCT04149158
- Lead Sponsor
- Fytexia
- Brief Summary
This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich extract, Sinetrol® Xpur, on fat mass accumulation and body weight management improvement.Subjects were overweight or obese and received polyphenol supplement or placebo. A 4-week follow-up as performed to evaluate its effect after supplementation stop.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 77
Inclusion Criteria
- overweight or obese (25 kg.m-2<BMI<42.5kg.m-2)
- healthy
Exclusion Criteria
- metabolic or chronical disease with treatments (i.e.: diabetes, dyslipidemia, thyroiditis, inflammatory disease, immunological disease, infectious disease, asthma, anxiety and depression)
- food allergy to the ingredients of the product (grapefruit, orange, caffeine, guarana)
- involved in the prior 6 months in a chronic treatment program, eating disorders history, subjected to weight reduction by surgery
- start or quit smoking, high alcohol consumption
- pregnant, breastfeeding, wanting to have a baby,
- menopausal women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Verum Sinetrol® Xpur Sinetrol® Xpur Placebo Placebo -
- Primary Outcome Measures
Name Time Method Change in total body fat percentage loss versus bodyweight week1; week16; week20
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UCAM
🇪🇸Murcia, Spain